Viking Therapeutics, Inc. ($VKTX)
Filing Information
| Accession Number | 0001193125-26-324448 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 30, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
370,184
Total Value
$4,947,888.41
P&L
+inf% (+$7,410,327.81)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock, par value $0.00001 per share | โ | Jul 28, 2026 | Grant/Award | 221,667 | $0.00 | $0.00 | 2,720,958 | Direct | โ | View Details | |
Director | Common Stock, par value $0.00001 per share | โ | Jul 29, 2026 | Sale | 148,517 | $33.32 | $4,947,888.41 | 2,572,441 | Direct | โ | View Details |